RecruitingNot ApplicableNCT07090356

Instrument-Assisted Soft Tissue Mobilization Versus PNF Stretching in Athletes With Piriformis Syndrome

Effects of Instrument-Assisted Soft Tissue Mobilization Versus Proprioceptive Neuromuscular Facilitation Stretching in Athletes With Piriformis Syndrome


Sponsor

Riphah International University

Enrollment

40 participants

Start Date

Jul 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A 12-month randomized controlled trial will be conducted at Pakistan Sports Board, Lahore, with 40 athletes (18-35 years) randomly allocated to IASTM (n=20) or PNF (n=20) groups. Interventions were administered 3 times/week for 4 weeks. Outcomes included Numeric Pain Rating Scale (NPRS), goniometric hip ROM, and Oswestry Disability Index (ODI).


Eligibility

Min Age: 18 YearsMax Age: 35 Years

Inclusion Criteria6

  • Professional Athletes aged 18 to 35 years.
  • Chronic pain in the buttock and hip area.
  • Inability to sit for a prolonged time.
  • Athletes having positive Faber test
  • Both male and female athletes
  • Practicing athletes who are in practice from last 2 years.

Exclusion Criteria5

  • Trauma history from last 6 months.
  • Other injuries excluding hip pain.
  • Systemic illness.
  • Pre-existing neurological conditions affecting the lower limbs
  • History of lower back surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInstrument-Assisted Soft Tissue Mobilization

IASTM therapy will be provided to participants in whom a specialized instrument will be used to apply controlled pressure over the piriformis muscle as well as surrounding soft tissues.

OTHERProprioceptive Neuromuscular Facilitation Stretching

PNF stretching (contract relax; hold relax) will be implemented to stretch participants' muscles as flexibly and with as much control as possible.


Locations(1)

Pakistan Sports Board

Lahore, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07090356


Related Trials